Warning signs of problem use

TL;DR

• Morning use (eye-opener) = strong warning sign.
• Loss of control: more/longer than intended.
• Neglect of work, relationships, hobbies.
• Free help: SafeZone.ch (chat) or local addiction counseling.

DSM-5 Cannabis Use Disorder criteria

• ≥2 of 11 symptoms in 12 months: tolerance, withdrawal, craving, failed reduction, time-consuming, giving up activities, continued use despite problems…
• Mild: 2–3, moderate: 4–5, severe: ≥6 symptoms.
• About 9 % of users develop dependence (Anthony 1994) — up to 17 % if initiation <18 y.

Psychological and social dynamics of problematic consumption

The transition from recreational to problematic cannabis use is usually gradual and often eludes the conscious awareness of those affected. A key indicator of this dynamic is the functional instrumentalisation of the substance. As soon as cannabis is no longer used exclusively in social settings, but specifically to cope with negative emotions, stress, or sleep disorders, the risk of psychological dependence increases massively. In these cases, the substance takes on the role of a dysfunctional coping mechanism, which blocks the development of healthy, active problem-solving strategies for everyday challenges and leads to emotional instability in the long term.

In parallel with intrapsychic processes, the social interactions of the affected individuals usually change as well. A gradual withdrawal from their previous circle of friends, the neglect of long-standing hobbies, and the avoidance of family obligations are classic warning signs. Often, the social focus shifts towards people who also consume intensively, which normalises one's own consumption and filters out critical feedback from one's environment. This social narrowing intensifies isolation and makes it more difficult for those affected to regain control over their behaviour, as corrective social impulses from the outside are increasingly lacking.

• Shift in motivation from recreational enjoyment to emotional regulation and stress management.
• Gradual withdrawal from social contacts outside the consumption scene.
• Neglect of responsibilities in education, work, or family structures.
• Concealing or downplaying the quantities consumed to one's social circle.

Physical and cognitive side effects

In addition to psychological changes, chronic and high-dose cannabis use often leads to significant cognitive impairment. Those affected frequently report a noticeable deterioration in short-term memory, difficulty concentrating, and a reduced attention span. These deficits make managing daily school or professional life significantly more difficult. In addition, there is often a pronounced lack of drive, where even simple daily tasks are perceived as insurmountable hurdles. Although these cognitive limitations are usually reversible after a period of abstinence, they place a massive burden on the performance and self-esteem of those affected during active use.

On a physical level, problematic use manifests primarily through the development of tolerance and withdrawal symptoms. When the body is accustomed to the regular intake of cannabinoids, sudden cessation or reduction leads to physical reactions. Typical symptoms include heavy sweating, inner restlessness, loss of appetite, and pronounced sleep disturbances, which are often accompanied by vivid dreams. As a result, many of those affected consume again to alleviate these unpleasant withdrawal symptoms, creating a vicious circle. Chronic coughing or breathing difficulties caused by inhaling combustion products are also physical warning signs that should be taken seriously.

• Noticeable decline in memory retention and concentration in daily life.
• Physical withdrawal symptoms such as sleep disturbances, night sweats, and loss of appetite during breaks in consumption.
• Development of a tolerance that requires increasingly higher doses to achieve the same effect.
• Persistent lack of drive and neglect of physical hygiene or fitness.

Swiss context: Legal and institutional framework

In Switzerland, the legal situation regarding cannabis is clearly regulated and has a direct influence on risk assessment in everyday life. If the total THC content is below one percent, the product is not considered a narcotic within the meaning of the Narcotics Act. If the content is above this, consumption is illegal and can be punished with a fixed penalty. The regulation is particularly strict in road traffic: a strict zero-tolerance practice applies here, with a limit of 1.5 micrograms of THC per litre of blood. Anyone caught at the wheel with this value or above is deemed unfit to drive, which entails far-reaching legal and financial consequences.

For individuals who feel their consumption is problematic or who have health-related questions, the Swiss healthcare system offers a dense support network. Since August 2022, medical cannabis has been directly prescribable by a doctor without a BAG exceptional permit, which facilitates medical supervision. At the same time, scientifically monitored pilot trials are underway in various cities to investigate regulated sales in order to gain insights for a future cannabis policy. In the event of acute poisoning or uncertainty regarding synthetic cannabinoids, the emergency hotline of Tox Info Suisse is available. In addition, Swissmedic and the Federal Office of Public Health monitor the quality and safety of products in circulation.

• Limit of under one percent total THC for legal classification in Switzerland.
• Strict zero-tolerance practice regarding unfitness to drive in road traffic from 1.5 micrograms of THC per litre of blood.
• Direct medical prescribability of medical cannabis since August 2022 without a BAG exceptional permit.
• Use of emergency consultation services such as Tox Info Suisse in case of suspected contaminated products.

FAQ